Featured Research

from universities, journals, and other organizations

Number Of Cerebral Cells At Embryonic Development Stage Controlled By Newly Discovered Mechanism

Date:
February 23, 2009
Source:
Instituto de Investigaciones Biomédicas Alberto Sols
Summary:
Researchers have discovered that a protein present in the nucleus of progenitor cells of the embryonic central nervous system forms part of the genetic mechanisms through which these cells transform into neurons and astrocytes, the two cell types that constitute the majority of the adult brain.

A group of researchers of the Instituto de Investigaciones Biomédicas Alberto Sols (a mixed centre of the Consejo Superior de Investigaciones Científicas and the Universidad Autónoma de Madrid) have discovered the participation of a protein denoted DREAM in the activation of genes that are necessary for the progenitor cells of embryonic brains to differentiate themselves into astrocytes.

The study, published in The Journal of Neuroscience, was directed by Dr. Mario Vallejo, and constitutes part of the doctoral thesis of Beatriz Cebolla and Antonio Fernández-Pérez, co-authors of the article.

Studies previously conducted in Dr. Vallejo's laboratory put forth that progenitor cells of the embryonic cerebral cortex are capable of responding to particular extracellular signals by increasing the levels of a second intracellular messenger called cyclic AMP. This second messenger is capable of activating mechanisms that alter the genetic program of progenitor cells and induce them to differentiate into astrocytes.

Working in collaboration with Dr. Alfonso Araque and Dr. Gertrudis Perea of the Instituto Cajal de Madrid (Consejo Superior de Investigaciones Científicas), also co-authors of the study, the researchers determined that the cyclic AMP produced activates the entry of calcium from the extracellular environment into the cell, and that calcium is responsible for the genetic effects of cyclic AMP. Among others, this discovery suggested that a possible mechanism by which calcium could mediate cyclic AMP effects over the expression of genes crucial for the differentiation of astrocytes could be through the activation of the DREAM protein. It is already well known that DREAM is a transcription factor, which means that it is a protein capable of directly regulating the expression of certain genes, and that its activity is regulated by calcium.

The research team discovered that DREAM regulates the activation of essential genes for the differentiation of astrocytes. When DREAM is not present, progenitor cells can not differentiate into astrocytes after being brought in contact with signals that act through the production of cyclic AMP. Nevertheless, these cells do not lose their differentiation capability, since they can transform into astrocytes as a response to different signals that do not require the production of this second messenger.

The research group managed by Dr. Vallejo observed that during the postnatal period, a period during which most astrocytes are generated, the brains of mice lacking DREAM contained an abnormally low number of these cells. Surprisingly, while gathering this data, the researchers noticed that the brains of mice lacking DREAM contained an abnormally high number of neurons. 

Taking into consideration that during the development of the brain, the neural progenitors produce neurons before producing astrocytes, these results indicate that DREAM takes part in the mechanism that blocks the production of neurons while activating the production of astrocytes. In the brains of mice lacking DREAM, compensation mechanisms take place that ensure that the adult animals would produce an abnormally high number of astrocytes during their lifetime, reinforcing the theory that the relation between the number of neurons and astrocytes has a great functional importance. Therefore, the lack of DREAM produces brains with a higher number of cells.

The authors of the study have emphasized the importance of the cyclic AMP-calcium-DREAM system in the mechanisms responsible for the production of astrocytes and controlling the number of neurons and astrocytes produced from neuronal progenitors during the development of the brain.


Story Source:

The above story is based on materials provided by Instituto de Investigaciones Biomédicas Alberto Sols. Note: Materials may be edited for content and length.


Journal Reference:

  1. Cebolla et al. DREAM Mediates cAMP-Dependent, Ca2 -Induced Stimulation of GFAP Gene Expression and Regulates Cortical Astrogliogenesis. Journal of Neuroscience, 2008; 28 (26): 6703 DOI: 10.1523/JNEUROSCI.0215-08.2008

Cite This Page:

Instituto de Investigaciones Biomédicas Alberto Sols. "Number Of Cerebral Cells At Embryonic Development Stage Controlled By Newly Discovered Mechanism." ScienceDaily. ScienceDaily, 23 February 2009. <www.sciencedaily.com/releases/2009/02/090213070922.htm>.
Instituto de Investigaciones Biomédicas Alberto Sols. (2009, February 23). Number Of Cerebral Cells At Embryonic Development Stage Controlled By Newly Discovered Mechanism. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/02/090213070922.htm
Instituto de Investigaciones Biomédicas Alberto Sols. "Number Of Cerebral Cells At Embryonic Development Stage Controlled By Newly Discovered Mechanism." ScienceDaily. www.sciencedaily.com/releases/2009/02/090213070922.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins